Temple University Hospital now has the latest technology in treating a rare stomach disease known as gastroparesis.
This disease affects about five percent of the population and Temple hospital has become a referral for patients. The disorder slows or stops food from passing through the stomach and into the small intestine, causing nausea and vomiting.
“Gastroparesis is predominantly more common in patients with diabetes,” said Director of the GI Mobility Lab Dr. Henry Parkman.
The university’s hospital is one of three hospitals on the east coast that has implemented a new treatment for the disorder. The Enterra 2 system is implanted inside the patient through surgery, and generates a mild electrical pulse to treat chronic nausea and vomiting. It is designed for patients between the ages of 18 and 70.
According to Parkman, the Enterra 2 has a longer battery that lasts about 5 years so the patient doesn’t have to undergo as many surgeries. This form of treatment is for the most severe cases of gastroparesis.